Commentary: once-daily aminoglycoside dosing: where are we now?
Martin
Janet E
JE
Evidence-Based Prescribing Initiative, London Health Sciences Centre, London, Ontario, Canada. janet.martin@lhsc.on.ca
D000583:Amikacin / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood; D000617:Aminoglycosides / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood*; D003428:Cross Infection / Q000188:drug therapy / Q000378:metabolism; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D007362:Intensive Care Units
D000617:Aminoglycosides; D000583:Amikacin